Abstract
Parkinson’s disease (PD) is a common, degenerative disorder of the central nervous system. Individuals experience predominantly extrapyramidal symptoms including resting tremor, rigidity, bradykinesia, gait abnormalities, cognitive impairment, depression, and neurobehavioral concerns. Cognitive impairments associated with PD are diverse, including difficulty with attention, processing speed, executive functioning, memory recall, visuospatial functions, word-retrieval, and naming. Deep brain stimulation (DBS) of the subthalamic nucleus (STN) or globus pallidus internus (GPi) is FDA approved and has been shown to be effective in reducing motor symptoms of PD. Studies have found that stimulating STN and GPi are equally effective at improving motor symptoms and dyskinesias; however, there has been discrepancy as to whether the cognitive, behavioral, and mood symptoms are affected differently between the two targets. The present study used random-effects meta-analytic models along with a novel p-curve analytic procedure to compare the potential cognitive and emotional impairments associated with STN-DBS in the current literature to those associated with GPi-DBS. Forty-one articles were reviewed with an aggregated sample size of 1622 patients. Following STN-DBS, small declines were found in psychomotor speed, memory, attention, executive functions, and overall cognition; and moderate declines were found in both semantic and phonemic fluency. However, GPi-DBS resulted in fewer neurocognitive declines than STN-DBS (small declines in attention and small-moderate declines in verbal fluency). With regards to its effect on depression symptomatology, both GPi-DBS and STN-DBS resulted in lower levels of depressive symptoms post-surgery. From a neurocognitive standpoint, both GPi-DBS and STN-DBS produce subtle cognitive declines but appears to be relatively well tolerated.
Similar content being viewed by others
References
Anderson, V. C., Burchiel, K. J., Hogarth, P., Favre, J., & Hammerstad, J. P. (2005). Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease. Archives of Neurology, 62(4), 554–560. doi:10.1001/archneur.62.4.554.
Ardouin, C., Pillon, B., Peiffer, E., Bejjani, P., Limousin, P., Damier, P., et al. (1999). Bilateral subthalamic or pallidal stimulation for Parkinson’s disease affects neither memory nor executive functions: a consecutive series of 62 patients. Annals of Neurology, 46(2), 217–223.
Auclair-Ouellet, N., Chantal, S., Cantin, L., Prud’homme, M., Langlois, M., & Macoir, J. (2011). Transient executive dysfunction following STNDBS in Parkinson’s disease. Canadian Journal of Neurological Sciences, 38(2), 360–363.
Benabid, A. L., Chabardes, S., Mitrofanis, J., & Pollak, P. (2009). Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson’s disease. Lancet Neurology, 8(1), 67–81. doi:10.1016/S1474-4422(08)70291-6.
Castelli, L., Perozzo, P., Zibetti, M., Crivelli, B., Morabito, U., Lanotte, M., et al. (2006). Chronic deep brain stimulation of the subthalamic nucleus for Parkinson’s disease: effects on cognition, mood, anxiety and personality traits. European Neurology, 55(3), 136–144. doi:10.1159/000093213.
Castelli, L., Rizzi, L., Zibetti, M., Angrisano, S., Lanotte, M., & Lopiano, L. (2010). Neuropsychological changes 1-year after subthalamic DBS in PD patients: a prospective controlled study. Parkinsonism & Related Disorders, 16(2), 115–118. doi:10.1016/j.parkreldis.2009.08.010.
Celesia, G. G., & Wanamaker, W. M. (1972). Psychiatric disturbances in Parkinson’s disease. Diseases of the Nervous System, 33(9), 577–583.
Cohen, J. (1992). A power primer. Psychological Bulletin, 112(1), 155–159.
Cummings, J., & Masterman, D. L. (1999). Depression in patients with Parkinson’s disease. International Journal of Geriatric Psychiatry, 14(9), 711–718.
Daniels, C., Krack, P., Volkmann, J., Pinsker, M. O., Krause, M., Tronnier, V., et al. (2010). Risk factors for executive dysfunction after subthalamic nucleus stimulation in Parkinson’s disease. Movement Disorders, 25(11), 1583–1589. doi:10.1002/mds.23078.
Denheyer, M., Kiss, Z. H., & Haffenden, A. M. (2009). Behavioral effects of subthalamic deep brain stimulation in Parkinson’s disease. Neuropsychologia, 47(14), 3203–3209. doi:10.1016/j.neuropsychologia.2009.07.022.
Dubois, B., & Pillon, B. (1997). Cognitive deficits in Parkinson’s disease. Journal of Neurology, 244(1), 2–8.
Fasano, A., Romito, L. M., Daniele, A., Piano, C., Zinno, M., Bentivoglio, A. R., et al. (2010). Motor and cognitive outcome in patients with Parkinson’s disease 8 years after subthalamic implants. Brain, 133(9), 2664–2676. doi:10.1093/brain/awq221.
Fields, J. A., Troster, A. I., Wilkinson, S. B., Pahwa, R., & Koller, W. C. (1999). Cognitive outcome following staged bilateral pallidal stimulation for the treatment of Parkinson’s disease. Clinical Neurology and Neurosurgery, 101(3), 182–188.
Follett, K. A., Weaver, F. M., Stern, M., Hur, K., Harris, C. L., Luo, P., et al. (2010). Pallidal versus subthalamic deep-brain stimulation for Parkinson’s disease. New England Journal of Medicine, 362(22), 2077–2091. doi:10.1056/NEJMoa0907083.
Fraraccio, M., Ptito, A., Sadikot, A., Panisset, M., & Dagher, A. (2008). Absence of cognitive deficits following deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson’s disease. Archives of Clinical Neuropsychology, 23(4), 399–408. doi:10.1016/j.acn.2008.02.001.
Funkiewiez, A., Ardouin, C., Cools, R., Krack, P., Fraix, V., Batir, A., et al. (2006). Effects of levodopa and subthalamic nucleus stimulation on cognitive and affective functioning in Parkinson’s disease. Movement Disorders, 21(10), 1656–1662. doi:10.1002/mds.21029.
Gologorsky, Y., Ben-Haim, S., Moshier, E. L., Godbold, J., Tagliati, M., Weisz, D., & Alterman, R. L. (2011). Transgressing the ventricular wall during subthalamic deep brain stimulation surgery for Parkinson disease increases the risk of adverse neurological sequelae. Neurosurgery, 69(2), 294–300.
Green, J., McDonald, W. M., Vitek, J. L., Haber, M., Barnhart, H., Bakay, R. A., et al. (2002). Neuropsychological and psychiatric sequelae of pallidotomy for PD: clinical trial findings. Neurology, 58(6), 858–865.
Groiss, S. J., Wotjecki, L., Sudmeyer, M., & Schnitzler, A. (2009). Deep brain stimulation in Parkinson’s disease. Therapeutic Advances in Neurological Disorders, 2(6), 20–28.
Heo, J. H., Lee, K. M., Paek, S. H., Kim, M. J., Lee, J. Y., Kim, J. Y., et al. (2008). The effects of bilateral subthalamic nucleus deep brain stimulation (STN DBS) on cognition in Parkinson disease. Journal of Neurological Sciences, 273(1–2), 19–24. doi:10.1016/j.jns.2008.06.010.
Higginson, C. I., Wheelock, V. L., Levine, D., King, D. S., Pappas, C. T., & Sigvardt, K. A. (2009). The clinical significance of neuropsychological changes following bilateral subthalamic nucleus deep brain stimulation for Parkinson’s disease. Journal of Clinical and Experimental Neuropsychology, 31(1), 65–72. doi:10.1080/13803390801982734.
Ishihara, L., & Brayne, C. (2006). A systematic review of depression and mental illness preceding Parkinson’s disease. Acta Neurologica Scandinavica, 113(4), 211–220. doi:10.1111/j.1600-0404.2006.00579.x.
Jahanshahi, M., Obeso, I., Baunez, C., Alegre, M., & Krack, P. (2015). Parkinson’s disease, the subthalamic nucleus, inhibition, and impulsivity. Movement Disorders, 30(2), 128–140. doi:10.1002/mds.26049.
Kalbe, E., Voges, J., Weber, T., Haarer, M., Baudrexel, S., Klein, J. C., et al. (2009). Frontal FDG-PET activity correlates with cognitive outcome after STN-DBS in Parkinson disease. Neurology, 72(1), 42–49. doi:10.1212/01.wnl.0000338536.31388.f0.
Kim, H. J., Jeon, B. S., Yun, J. Y., Kim, Y. E., Yang, H. J., & Paek, S. H. (2013). Initial cognitive dip after subthalamic deep brain stimulation in Parkinson disease. Journal of Neurology, 260(8), 2130–2133. doi:10.1007/s00415-013-6959-2.
Kishore, A., Rao, R., Krishnan, S., Panikar, D., Sarma, G., Sivasanakaran, M. P., et al. (2010). Long-term stability of effects of subthalamic stimulation in Parkinson’s disease: Indian Experience. Movement Disorders, 25(14), 2438–2444. doi:10.1002/mds.23269.
Klempirova, O., Jech, R., Urgosik, D., Klempir, J., Spackova, N., Roth, J., et al. (2007). Deep brain stimulation of the subthalamic nucleus and cognitive functions in Parkinson’s disease. Prague Medical Report, 108(4), 315–323.
Kowal, S. L., Dall, T. M., Chakrabarti, R., Storm, M. V., & Jain, A. (2013). The current and projected economic burden of Parkinson’s disease in the United States. Movement Disorders, 28(3), 311–318. doi:10.1002/mds.25292.
Odekerken, V. J., van Laar, T., Staal, M. J., Mosch, A., Hoffmann, C. F., Nijssen, P. C., et al. (2013). Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson’s disease (NSTAPS study): a randomised controlled trial. Lancet Neurology, 12(1), 37–44. doi:10.1016/S1474-4422(12)70264-8.
Okun, M. S., & Foote, K. D. (2010). Parkinson’s disease DBS: what, when, who and why? the time has come to tailor DBS targets. Expert Review of Neurotherapeutics, 10(12), 1847–1857.
Okun, M. S., Fernandez, H. H., Wu, S. S., Kirsch-Darrow, L., Bowers, D., Bova, F., et al. (2009). Cognition and mood in Parkinson’s disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial. Annals of Neurology, 65(5), 586–595. doi:10.1002/ana.21596.
Ory-Magne, F., Brefel-Courbon, C., Simonetta-Moreau, M., Fabre, N., Lotterie, J. A., Chaynes, P., et al. (2007). Does ageing influence deep brain stimulation outcomes in Parkinson’s disease? Movement Disorders, 22(10), 1457–1463. doi:10.1002/mds.21547.
Parsons, T. D., Rogers, S. A., Braaten, A. J., Woods, S. P., & Troster, A. I. (2006). Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson’s disease: a meta-analysis. Lancet Neurology, 5(7), 578–588. doi:10.1016/S1474-4422(06)70475-6.
Pillon, B., Ardouin, C., Damier, P., Krack, P., Houeto, J. L., Klinger, H., et al. (2000). Neuropsychological changes between “off” and “on” STN or GPi stimulation in Parkinson’s disease. Neurology, 55(3), 411–418.
Rinehardt, E., Duff, K., Schoenberg, M., Mattingly, M., Bharucha, K., & Scott, J. (2010). Cognitive change on the repeatable battery of neuropsychological status (RBANS) in Parkinson’s disease with and without bilateral subthalamic nucleus deep brain stimulation surgery. Clinical Neuropsychology, 24(8), 1339–1354. doi:10.1080/13854046.2010.521770.
Rizzone, M. G., Fasano, A., Daniele, A., Zibetti, M., Merola, A., Rizzi, L., et al. (2014). Long-term outcome of subthalamic nucleus DBS in Parkinson’s disease: from the advanced phase towards the late stage of the disease? Parkinsonism & Related Disorders, 20(4), 376–381. doi:10.1016/j.parkreldis.2014.01.012.
Rothlind, J. C., York, M. K., Carlson, K., Luo, P., Marks, W. J., Jr., Weaver, F. M., et al. (2014). Neuropsychological changes following deep brain stimulation surgery for Parkinson’s disease: comparisons of treatment at pallidal and subthalamic targets versus best medical therapy. Journal of Neurology, Neurosurgery and Psychiatry. doi:10.1136/jnnp-2014-308119.
Rouaud, T., Dondaine, T., Drapier, S., Haegelen, C., Lallement, F., Peron, J., et al. (2010). Pallidal stimulation in advanced Parkinson’s patients with contraindications for subthalamic stimulation. Movement Disorders, 25(12), 1839–1846. doi:10.1002/mds.23171.
Russmann, H., Ghika, J., Villemure, J. G., Robert, B., Bogousslavsky, J., Burkhard, P. R., et al. (2004). Subthalamic nucleus deep brain stimulation in Parkinson disease patients over age 70 years. Neurology, 63(10), 1952–1954.
Saez-Zea, C., Escamilla-Sevilla, F., Katati, M. J., & Minguez-Castellanos, A. (2012). Cognitive effects of subthalamic nucleus stimulation in Parkinson’s disease: a controlled study. European Neurology, 68(6), 361–366. doi:10.1159/000341380.
Simonsohn, U., Nelson, L. D., & Simmons, J. P. (2014). P-curve: a key to the file-drawer. Journal of Experimental Psychology: General, 143(2), 534–547. doi:10.1037/a0033242.
Smeding, H. M., Speelman, J. D., Huizenga, H. M., Schuurman, P. R., & Schmand, B. (2011). Predictors of cognitive and psychosocial outcome after STN DBS in Parkinson’s Disease. Journal of Neurology, Neurosurgery and Psychiatry, 82(7), 754–760. doi:10.1136/jnnp.2007.140012.
Starkstein, S. E., Preziosi, T. J., Bolduc, P. L., & Robinson, R. G. (1990). Depression in Parkinson’s disease. Journal of Nervous and Mental Disease, 178(1), 27–31.
Tagliati, M. (2012). Turning tables: should GPi become the preferred DBS target for Parkinson disease? Neurology, 79(1), 19–20. doi:10.1212/WNL.0b013e31825dce96.
Tsai, S. T., Lin, S. H., Lin, S. Z., Chen, J. Y., Lee, C. W., & Chen, S. Y. (2007). Neuropsychological effects after chronic subthalamic stimulation and the topography of the nucleus in Parkinson’s disease. Neurosurgery, 61(5), E1024–1029. doi:10.1227/01.neu.0000303198.95296.6f. discussion E1029-1030.
Vingerhoets, F. J., Villemure, J. G., Temperli, P., Pollo, C., Pralong, E., & Ghika, J. (2002). Subthalamic DBS replaces levodopa in Parkinson’s disease: two-year follow-up. Neurology, 58(3), 396–401.
Williams, A. E., Arzola, G. M., Strutt, A. M., Simpson, R., Jankovic, J., & York, M. K. (2011). Cognitive outcome and reliable change indices two years following bilateral subthalamic nucleus deep brain stimulation. Parkinsonism & Related Disorders, 17(5), 321–327. doi:10.1016/j.parkreldis.2011.01.011.
Witt, K., Daniels, C., Reiff, J., Krack, P., Volkmann, J., Pinsker, M. O., et al. (2008). Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson’s disease: a randomised, multicentre study. Lancet Neurology, 7(7), 605–614. doi:10.1016/S1474-4422(08)70114-5.
Yaguez, L., Costello, A., Moriarty, J., Hulse, N., Selway, R., Clough, C., et al. (2014). Cognitive predictors of cognitive change following bilateral subthalamic nucleus deep brain stimulation in Parkinson’s disease. Journal of Clinical Neuroscience, 21(3), 445–450. doi:10.1016/j.jocn.2013.06.005.
Yamanaka, T., Ishii, F., Umemura, A., Miyata, M., Horiba, M., Oka, Y., et al. (2012). Temporary deterioration of executive function after subthalamic deep brain stimulation in Parkinson’s disease. Clinical Neurology and Neurosurgery, 114(4), 347–351. doi:10.1016/j.clineuro.2011.11.009.
York, M. K., Dulay, M., Macias, A., Levin, H. S., Grossman, R., Simpson, R., et al. (2008). Cognitive declines following bilateral subthalamic nucleus deep brain stimulation for the treatment of Parkinson’s disease. Journal of Neurology, Neurosurgery and Psychiatry, 79(7), 789–795. doi:10.1136/jnnp.2007.118786.
Zahodne, L. B., Okun, M. S., Foote, K. D., Fernandez, H. H., Rodriguez, R. L., Kirsch-Darrow, L., et al. (2009). Cognitive declines one year after unilateral deep brain stimulation surgery in Parkinson’s disease: a controlled study using reliable change. Clinical Neuropsychology, 23(3), 385–405. doi:10.1080/13854040802360582.
Zangaglia, R., Pacchetti, C., Pasotti, C., Mancini, F., Servello, D., Sinforiani, E., et al. (2009). Deep brain stimulation and cognitive functions in Parkinson’s disease: a three-year controlled study. Movement Disorders, 24(11), 1621–1628. doi:10.1002/mds.22603.
Zibetti, M., Merola, A., Rizzi, L., Ricchi, V., Angrisano, S., Azzaro, C., et al. (2011). Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson’s disease. Movement Disorders, 26(13), 2327–2334. doi:10.1002/mds.23903.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflicts of interest.
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(DOC 30 kb)
Rights and permissions
About this article
Cite this article
Combs, H.L., Folley, B.S., Berry, D.T.R. et al. Cognition and Depression Following Deep Brain Stimulation of the Subthalamic Nucleus and Globus Pallidus Pars Internus in Parkinson’s Disease: A Meta-Analysis. Neuropsychol Rev 25, 439–454 (2015). https://doi.org/10.1007/s11065-015-9302-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11065-015-9302-0